Sung Keun Kang

This inventor holds 10 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 6 EPO patents. Top assignees: R Bio Co., Ltd., Rnl Bio Co., Ltd., K-Stemcell Co., Ltd.. Active years: 2012-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sung Keun Kang. Retrieved from https://idiyas.com/inventor/sung-keun-kang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 8)

% Patents Active = 90.0

CIPO Patents = 2

EPO Patents = 6 (Patent Applications = 11)

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 11(Granted Patents)

Company Filing History:

Seoul National University

patents

6. 4 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2012-2024

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11932874 - Method for culturing mesenchymal stem cells using gamma-irradiated serum (2024-03-19),

2. 10815459 - Method for manufacturing stem cell having appropriate size for intravascular administration (2020-10-27),

3. 10287551 - Medium composition for culturing stem cells (2019-05-14),

4. 9982234 - Culture medium composition for improving regenerative capacity of stem cells, and stem cell culturing method using same (2018-05-29),

5. 9708584 - Medium composition for rejuvenating stem cells (2017-07-18),

6. 9433645 - Method and composition for preventing stem cell disruption and aggregation (2016-09-06),

7. 8871513 - Culture medium composition for culturing amnion-derived mesenchymal stem cell, and method for culturing amnion-derived mesenchymal stem cell by using same (2014-10-28),

8. 8808682 - Method for inducing migration of adipose-derived adult stem cells (2014-08-19),

9. 8455251 - Method for isolating and culturing adult stem cells derived from human amniotic epithelium (2013-06-04),

10. 8124832 - Method for producing cloned dog (2012-02-28),

Title: Innovations by Sung Keun Kang

Introduction

Sung Keun Kang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of stem cell research, holding a total of 10 patents. His work focuses on innovative methods for culturing and preparing stem cells, which are crucial for advancements in cell therapy.

Latest Patents

One of his latest patents is a method for culturing mesenchymal stem cells using gamma-irradiated serum. This invention improves the adhesion and proliferation rate of stem cells by utilizing a medium that contains gamma-irradiated serum and an antioxidant. This method addresses the challenge of reduced efficiency in cell adhesion and proliferation when using gamma-irradiated fetal bovine serum (FBS), making it a valuable tool for producing stem cells for cell therapy.

Another notable patent is a method for manufacturing stem cells with an appropriate size for intravascular administration. This method focuses on preparing stem cells with a diameter ranging from 11-16 micrometers. The invention ensures that stem cells can effectively reach target tissues when administered into a vein, thereby enhancing the efficacy of cell therapy.

Career Highlights

Sung Keun Kang has worked with R Bio Co., Ltd., where he has contributed to various innovative projects in the field of biotechnology. His expertise in stem cell research has positioned him as a key figure in advancing therapeutic applications.

Collaborations

He has collaborated with notable coworkers, including Jeong Chan Ra and Il Seob Shin, who have also contributed to the field of stem cell research.

Conclusion

Sung Keun Kang's innovative work in stem cell research and his numerous patents highlight his significant impact on the field. His contributions are paving the way for advancements in cell therapy, showcasing the importance of innovation in medical science.

Profile summary based on public USPTO records.